Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients With Gout

11th Mar, 2026

Rheumatology

Journal of the American Medical Association

This cohort study evaluates the association between achieving a serum urate treatment target lower than 6 mg/dL and cardiovascular events among patients with gout who were newly prescribed urate-lowering treatment.

Published By: Journal of the American Medical Association

Rheumatology

11th Mar, 2026

The New England Journal of Medicine

Baker’s Cyst

Rheumatology

11th Mar, 2026

The New England Journal of Medicine

Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus

Rheumatology

11th Mar, 2026

The Lancet

[Clinical Picture] Pneumatosis cystoides intestinalis in overlap syndrome

Rheumatology

11th Mar, 2026

The Lancet

[Viewpoint] Oral glucocorticoid pulse therapy: a modest change in clinical practice with major benefits

Rheumatology

11th Mar, 2026

The Lancet

[Review] The path to interception in psoriatic disease: from conceptual clarity to clinical translation

Rheumatology

11th Mar, 2026

The Lancet

[Articles] Clinical phenotypes, classification, and long-term outcomes of childhood-onset Sjögren's disease into adulthood: a single-centre cohort study

Rheumatology

11th Mar, 2026

The Lancet

[Articles] Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries

Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients With Gout

Related Articles

Baker’s Cyst

Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus

[Clinical Picture] Pneumatosis cystoides intestinalis in overlap syndrome

[Viewpoint] Oral glucocorticoid pulse therapy: a modest change in clinical practice with major benefits

[Review] The path to interception in psoriatic disease: from conceptual clarity to clinical translation

[Articles] Clinical phenotypes, classification, and long-term outcomes of childhood-onset Sjögren's disease into adulthood: a single-centre cohort study

[Articles] Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries

Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients With Gout

Related Articles

Baker’s Cyst

Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus

[Clinical Picture] Pneumatosis cystoides intestinalis in overlap syndrome

[Viewpoint] Oral glucocorticoid pulse therapy: a modest change in clinical practice with major benefits

[Review] The path to interception in psoriatic disease: from conceptual clarity to clinical translation

[Articles] Clinical phenotypes, classification, and long-term outcomes of childhood-onset Sjögren's disease into adulthood: a single-centre cohort study

[Articles] Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries